Cell Signaling Technology

eIF3A Antibody

#2538 · $317

65
Evidence Score · Well-Established
Used by 196 independent labs across 208 papers. How we score this →
100
Citing papers
17k
Combined citations
Supplier page Find this product

Research areas

Cancer-related molecular mechanisms research9MicroRNA in disease regulation8Ubiquitin and proteasome pathways6Mitochondrial Function and Pathology5Circular RNAs in diseases5Epigenetics and DNA Methylation5DNA Repair Mechanisms5interferon and immune responses5

Papers citing this product

1
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Nature Cell Biology·2010·1.3k cit.·DOI
2
Ultrasmall copper-based nanoparticles for reactive oxygen species scavenging and alleviation of inflammation related diseases
Nature Communications·2020·848 cit.·DOI
3
The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression
Journal of Clinical Investigation·2001·576 cit.·DOI
4
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Nature Communications·2015·549 cit.·DOI
5
The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression
Journal of Clinical Investigation·2001·536 cit.·DOI
6
Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation
The Journal of Experimental Medicine·2005·494 cit.·DOI
7
Circular RNA DLGAP4 Ameliorates Ischemic Stroke Outcomes by Targeting miR-143 to Regulate Endothelial-Mesenchymal Transition Associated with Blood–Brain Barrier Integrity
Journal of Neuroscience·2017·381 cit.·DOI
8
Ferroptosis driven by radical oxidation of n-6 polyunsaturated fatty acids mediates acetaminophen-induced acute liver failure
Cell Death and Disease·2020·335 cit.·DOI
9
In utero supplementation with methyl donors enhances allergic airway disease in mice
Journal of Clinical Investigation·2008·330 cit.·DOI
10
Iterative Design and Optimization of Initially Inactive Proteolysis Targeting Chimeras (PROTACs) Identify VZ185 as a Potent, Fast, and Selective von Hippel–Lindau (VHL) Based Dual Degrader Probe of BRD9 and BRD7
Journal of Medicinal Chemistry·2018·330 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
eIF3A (D51F4) Rabbit Monoclonal AntibodyRabbitCell Signaling Technology65$161,384100
eIF3A (D51F4) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology65$8658

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.